Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
186 Leser
Artikel bewerten:
(0)

Charkit to Partner With Panacea Life Sciences on Hemp-Derived CBD Products


Global agreement covers distribution of Panacea Pure hemp oil, CBD isolates and CBD distillates to companies in the cosmetics, personal care and beauty industries.

NORWALK, Connecticut, March 13, 2019 /PRNewswire/ -- Jay Lang, President, Charkit Chemical Company, announced that the company has signed an exclusive representation agreement with Panacea Life Sciences of Golden, Colorado to distribute hemp-derived cannabidiol (CBD) products to the cosmetic and personal care industry.

With this agreement, Charkit will be responsible for the domestic and international distribution of Panacea Pure hemp oil and hemp-derived CBD isolates, distillates and blends produced at Panacea's 43,000 square foot Center of Excellence in Golden, Colorado. The facility features an impressive infrastructure, with advanced laboratories, proprietary extraction methods and GMP-compliant manufacturing processes. Panacea Pure hemp CBD isolate is guaranteed to be 99.9% pure and the company's CBD distillate is available in full spectrum, broad spectrum and varying concentrations to fit all production needs. All Panacea Pure hemp products are non-GMO, pesticide-free, herbicide-free and THC-free.

According to Dan O'Neill, Vice President and Sales Group Leader at Charkit, "Huge consumer demand, coupled with the recent passage of the US Farm Bill, means the market for CBD products is exploding. Our customers in cosmetic and personal care have a need for these products and we are now ready to supply them with high-quality, high-performance ingredients from Panacea."

Panacea (panacealife.com) is a market leader in developing medically relevant formulations and products from the hemp plant. The company sources industrial hemp grown organically in the USA, then processes it using proprietary extraction techniques to produce hemp oil that is rich in cannabinoids and terpenes. The oil is then further optimized and refined, including the removal of any detectable THC, resulting in material that is highly bioavailable. Until recently, that material has only been used in Panacea's own line of branded supplement products. With this announcement, it is now available for cosmetic and personal care applications through Charkit.

Nick Cavarra, Vice President of Sales and Marketing at Panacea stated that "Charkit's exemplary reputation and focus on working only with the top manufacturers in their respective industries aligns perfectly with Panacea's mission of providing the purest hemp CBD oil in the market. Their customer-centric approach, attention to detail, and the trust they have established in the cosmetics and personal care market made partnering with Charkit an easy decision."

The CBD industry, currently estimated at $800 million, is expected to grow to $19 billion by 2022. Because cannabinoid receptors are found throughout the human body, product applications in the skin care, sun care, personal hygiene and beauty segments represents a significant growth opportunity for manufacturers and marketers.

To find out more about Charkit's CBD ingredients, please send an email to: cbd@charkit.com.

For more information about Charkit Chemical Company, please contact Shawn McManus at 203-299-3227 or sales@charkit.com or visit charkit.com.

About Charkit:
Founded in 1982 by Charles Hinnant, Charkit Chemical Company LLC offers a wide range of high-demand products to customers in the personal care, food, flavor & fragrance, water treatment, imaging, metal treatment, nutritional, pharmaceutical and specialty chemicals markets. For companies that require customized specialty chemical solutions, Charkit also provides custom sourcing, manufacturing, technical assistance and product development services through its partners. In 2017, Charkit received an equity investment from LeBaronBrown Industries LLC and became a subsidiary of LBB Specialties LLC. With the acquisition of American International Chemical LLC (AIC) in 2018, LBB Specialties' annual sales surpassed $200 million, further validating the company's position as a leader in the North American specialty chemical and ingredients distribution industry.

Charkit Chemical Company LLC
PO Box 90
Norwalk CT 06856-0090
www.charkit.com

Logo - https://mma.prnewswire.com/media/716198/Chartkit_LBB_Logo.jpg




© 2019 PR Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.